Literature DB >> 24707159

Ulcerative colitis flair induced by mesalamine suppositories hypersensitivity.

Hao Ding1, Xiao-Chang Liu1, Qiao Mei1, Jian-Ming Xu1, Xiang-Yang Hu1, Jing Hu1.   

Abstract

Mesalamine suppositories have been used widely for the treatment of distal ulcerative colitis and considered to be safer than systemic administration for its limited systemic absorption. However, previous studies have shown that mesalamine suppository occasionally causes severe hypersensitivity reactions including fever, rashes, colitis exacerbation and acute eosinophilic pneumonia. Here we present a 25-year-old woman with ulcerative colitis with bloody diarrhea accompanied by abdominal pain and fever which were aggravated after introduction of mesalamine suppositories. In light of symptom exacerbation of ulcerative colitis, increased inflammatory injury of colon mucosa shown by colonoscopy and elevated peripheral eosinophil count after mesalamine suppositories administration, and the Naranjo algorithm score of 10, the possibility of hypersensitivity reaction to mesalamine suppositories should be considered, warning us to be aware of this potential reaction after administration of mesalamine formulations even if it is the suppositories.

Entities:  

Keywords:  Hypersensitivity; Mesalamine suppositories; Sulfasalazine; Surgery; Ulcerative colitis

Mesh:

Substances:

Year:  2014        PMID: 24707159      PMCID: PMC3974543          DOI: 10.3748/wjg.v20.i13.3716

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Lung and skin hypersensitivity to 5-aminosalicylic acid.

Authors:  V le Gros; H Saveuse; G Lesur; N Brion
Journal:  BMJ       Date:  1991-04-20

2.  Diarrhea associated with mesalamine in a patient with chronic nongranulomatous enterocolitis.

Authors:  K D Fine; H E Sarles; B Cryer
Journal:  N Engl J Med       Date:  1998-03-26       Impact factor: 91.245

3.  Mesalazine-induced multi-organ hypersensitivity.

Authors:  Bruno Sposato; Maria Pia Allegri; Maria Piera Riccardi; Silvia Chigiotti; Cesira Nencioni; Barbara Ricciardi; Tiziana Carli; Alberto Cresti; Maria Grazia Perari; Maria Giovanna Migliorini; Mario Toti
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

4.  Adverse reactions during salicylazosulfapyridine therapy and the relation with drug metabolism and acetylator phenotype.

Authors:  K M Das; M A Eastwood; J P McManus; W Sircus
Journal:  N Engl J Med       Date:  1973-09-06       Impact factor: 91.245

Review 5.  Mesalamine delivery systems: do they really make much difference?

Authors:  Altamash I Qureshi; Russell D Cohen
Journal:  Adv Drug Deliv Rev       Date:  2005-01-06       Impact factor: 15.470

6.  Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion.

Authors:  M Campieri; G A Lanfranchi; S Boschi; C Brignola; G Bazzocchi; P Gionchetti; M R Minguzzi; A Belluzzi; G Labò
Journal:  Gut       Date:  1985-04       Impact factor: 23.059

7.  Exacerbation of chronic ulcerative colitis with mesalamine.

Authors:  J B Sturgeon; P Bhatia; D Hermens; P B Miner
Journal:  Gastroenterology       Date:  1995-06       Impact factor: 22.682

8.  Effect of olsalazine and mesalazine on human ileal and colonic (Na+ + K+)-ATPase. A possible diarrhogenic factor?

Authors:  C Scheurlen; H Allgayer; W Kruis; E Erdmann; T Sauerbruch
Journal:  Clin Investig       Date:  1993-04

9.  Mesalazine induced exacerbation of ulcerative colitis.

Authors:  K C Kapur; G T Williams; M C Allison
Journal:  Gut       Date:  1995-12       Impact factor: 23.059

10.  Acute eosinophilic pneumonia related to a mesalazine suppository.

Authors:  Jung Hyun Kim; June-Hyuk Lee; Eun-Suk Koh; Sung Woo Park; An-Soo Jang; Dojin Kim; Choon-Sik Park
Journal:  Asia Pac Allergy       Date:  2013-04-26
View more
  2 in total

1.  Acetylsalicylic acid-tris-hydroxymethyl-aminomethane reduces colon mucosal damage without causing gastric side effects in a rat model of colitis.

Authors:  Gabriella Varga; Melinda Ugocsai; Petra Hartmann; Norbert Lajkó; Réka Molnár; Szilárd Szűcs; Dávid Kurszán Jász; Dániel Érces; Miklós Ghyczy; Gábor Tóth; Mihály Boros
Journal:  Inflammopharmacology       Date:  2017-04-27       Impact factor: 4.473

2.  A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity Reactions.

Authors:  Haruka Hirono; Kazuhiko Watanabe; Katsuhiko Hasegawa; Terasu Honma; Yoichi Ajioka; Shogo Ohkoshi
Journal:  Am J Case Rep       Date:  2018-05-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.